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journal homepage: www.e- jmii .comLETTER TO THE EDITORThe detection and clinical impact
of vancomycin MIC among patients
with methicillin-resistant Staphylococcus
aureus bacteremiaDear Editor,
We readwith great interest the article by Yeh et al, reporting
the phenomenon of vancomycin minimal inhibitory concen-
tration (MIC) creep of methicillin-resistant Staphylococcus
aureus (MRSA) and its clinical impact on patients with MRSA
bacteremia in a tertiary hospital of northern Taiwan.1
Compared with isolates in both 2001 and 2005, Yeh et al
found that the vancomycin MICs for MRSA isolates increased
significantly in 2009. However, patients with high MICs
(MICs 1.5 mg/mL) did not have higher in-hospital mortality
than those with low MICs (MICs < 1.5 mg/mL).1
In this study, there were two interesting issues worth
further discussion. First, vancomycin MIC of the same
isolate would significantly decrease after storage for
months, tested by the vancomycin Etest.2 A prospective
study was conducted to measure the vancomycin and
daptomycin MICs of MRSA isolates using the Etest. In
addition to using the Etest at the time of isolation, they
repeated the Etest at 3 months, 6 months, and 9 months
after isolation.2 There were significant declines in both
the vancomycin and daptomycin MICs from the same iso-
lates at the 3-month interval. The MIC detection using
stored isolates might underestimate the real vancomycin
MICs.
Second, concerning the clinical outcomes of patients
with MRSA bacteremia, a meta-analysis showed that
isolates with high vancomycin MICs contributed to a higher
mortality,3 although a potential intrinsic strain-specific
virulence effect was also reported as an independent
factor on the clinical outcome.4 In a medical center of
southern Taiwan, we found 8.1% (5/118) patients
with heteroresistant vancomycin intermediate S. aureus
(hVISA).5 The MICs of these hVISA isolates were 2 mg/mL1684-1182/$36 Copyright ª 2013, Taiwan Society of Microbiology. Publ
http://dx.doi.org/10.1016/j.jmii.2013.03.003and patients with hVISA bacteremia had significantly
higher in-hospital mortality rates than non-hVISA patients
(60% vs. 17.5%). The distribution of hVISA in different
vancomycin MIC groups would impact the analysis of clin-
ical outcomes on these infections. So, in the Yeh et al
study, a lower hVISA rate in the high MIC group might act
as one potential factor leading to no difference in the in-
hospital mortality rates between the high and low vanco-
mycin MIC groups.
For surveillance purposes, we suggest that MIC mea-
surements need to be performed near the time of
isolation, to reduce the storage effect. The identification
of hVISA might be important for an appropriate choice of
antimicrobial agents and good clinical outcome in the
future.
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